CRMD
Income statement / Annual
Last year (2023), CorMedix Inc.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2023, CorMedix Inc.'s net income was -$46.34 M.
See CorMedix Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$0.00
|
$65,408.00
|
$190,936.00
|
$239,231.00
|
$283,266.00
|
$429,797.00
|
$329,327.00
|
$224,105.00
|
$210,130.00
|
$189,274.00
|
Cost of Revenue |
$205,562.00 |
$3,734.00 |
$148,938.00 |
$204,846.00 |
$373,234.00 |
$396,786.00 |
$114,964.00 |
$366,673.00 |
$318,718.00 |
$445,799.00 |
Gross Profit |
-$205,562.00 |
$61,674.00 |
$41,998.00 |
$34,385.00 |
-$89,968.00 |
$33,011.00 |
$214,363.00 |
-$142,568.00 |
-$108,588.00 |
-$256,525.00 |
Gross Profit Ratio |
0 |
0.94 |
0.22 |
0.14 |
-0.32 |
0.08 |
0.65 |
-0.64 |
-0.52 |
-1.36 |
Research and Development
Expenses |
$13.16 M
|
$10.68 M
|
$13.13 M
|
$13.38 M
|
$11.05 M
|
$18.82 M
|
$24.49 M
|
$15.74 M
|
$6.28 M
|
$1.32 M
|
General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$8.07 M
|
$8.65 M
|
$8.88 M
|
$10.26 M
|
$7.33 M
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$35.60 M
|
$20.01 M
|
$16.35 M
|
$13.88 M
|
$9.87 M
|
$8.07 M
|
$8.65 M
|
$8.88 M
|
$10.26 M
|
$7.33 M
|
Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Operating Expenses |
$48.75 M |
$30.69 M |
$29.48 M |
$27.26 M |
$20.92 M |
$26.90 M |
$33.14 M |
$24.62 M |
$16.55 M |
$8.65 M |
Cost And Expenses |
$48.96 M |
$30.69 M |
$29.48 M |
$27.46 M |
$21.29 M |
$27.29 M |
$33.25 M |
$24.99 M |
$16.86 M |
$9.09 M |
Interest Income |
$0.00 |
$326,016.00 |
$14,403.00 |
$116,065.00 |
$322,668.00 |
$36,618.00 |
$110,714.00 |
$126,774.00 |
$60,393.00 |
$2,714.00 |
Interest Expense |
$0.00 |
$26,515.00 |
$15,943.00 |
$33,226.00 |
$787,488.00 |
$1,873.00 |
$5,619.00 |
$1,311.00 |
$3,964.00 |
$2,087.00 |
Depreciation &
Amortization |
$205,562.00
|
$209,038.00
|
$177,020.00
|
$143,487.00
|
$73,286.00
|
$74,218.00
|
$36,886.00
|
$25,596.00
|
$15,076.00
|
$15,074.00
|
EBITDA |
-$48.75 M
|
-$30.30 M
|
-$29.44 M
|
-$27.10 M
|
-$20.69 M
|
-$26.83 M
|
-$32.81 M
|
-$24.61 M
|
-$16.58 M
|
-$8.88 M
|
EBITDA Ratio |
0 |
-463.21 |
-154.21 |
-113.3 |
-73.02 |
-62.42 |
-99.64 |
-109.81 |
-78.9 |
-46.94 |
Operating Income Ratio
|
0
|
-468.2
|
-154.18
|
-113.78
|
-74.16
|
-62.5
|
-99.97
|
-110.49
|
-79.26
|
-47.03
|
Total Other
Income/Expenses Net |
$2.62 M
|
$336,646.00
|
-$22,827.00
|
$23,674.00
|
-$485,976.00
|
-$179.00
|
-$190,899.00
|
-$8,172.00
|
-$1.59 M
|
-$11.55 M
|
Income Before Tax |
-$46.34 M |
-$30.29 M |
-$29.46 M |
-$27.20 M |
-$21.49 M |
-$26.83 M |
-$33.01 M |
-$24.64 M |
-$18.19 M |
-$20.45 M |
Income Before Tax Ratio
|
0
|
-463.05
|
-154.29
|
-113.69
|
-75.88
|
-62.42
|
-100.23
|
-109.96
|
-86.55
|
-108.06
|
Income Tax Expense |
-$2.00 |
-$585,617.00 |
-$1.25 M |
-$5.17 M |
-$5.06 M |
$36,439.00 |
-$31,267.00 |
$1,311.00 |
$3,964.00 |
$2,087.00 |
Net Income |
-$46.34 M |
-$29.70 M |
-$28.21 M |
-$22.03 M |
-$16.43 M |
-$26.83 M |
-$33.01 M |
-$24.64 M |
-$18.19 M |
-$20.45 M |
Net Income Ratio |
0 |
-454.1 |
-147.75 |
-92.08 |
-58.01 |
-62.42 |
-100.23 |
-109.96 |
-86.55 |
-108.06 |
EPS |
-0.91 |
-0.74 |
-0.75 |
-0.77 |
-0.68 |
-1.51 |
-2.99 |
-3.25 |
-2.9 |
-4.77 |
EPS Diluted |
-0.91 |
-0.74 |
-0.75 |
-0.77 |
-0.68 |
-1.51 |
-2.99 |
-3.25 |
-2.9 |
-4.77 |
Weighted Average Shares
Out |
$50.90 M
|
$40.14 M
|
$37.61 M
|
$28.56 M
|
$24.15 M
|
$17.82 M
|
$11.03 M
|
$7.59 M
|
$6.27 M
|
$4.29 M
|
Weighted Average Shares
Out Diluted |
$50.90 M
|
$40.27 M
|
$37.67 M
|
$28.56 M
|
$24.15 M
|
$17.82 M
|
$11.03 M
|
$7.59 M
|
$6.27 M
|
$4.29 M
|
Link |
|
|
|
|
|
|
|
|
|
|